IL17A and colorectal carcinoma: Interestingly, in the metastatic context, IL-17 levels can also be upregulated by treatment with vesicles derived from CRC cells stimulated with the P2X7 agonist ATP, suggesting that the cargo of these vesicles comprising ATP and miRNAs [6, 25] plays a role in modulating Th17 pathways.